title: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer.
authors.affiliation: Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton. johann.de-bono@icr.ac.uk.
authors.forename: Johann
authors.initials: J
authors.lastname: De Bono
authors.forename: Liji
authors.initials: L
authors.lastname: Shen
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*